EUVIMEDScopri EUVIMED
Video/Audio

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Lulu Zhang, Siqi Zhang, Wenyu Wu, Xingkai Wang, Jieting Shen, Dongyuan Wang, Kuan Hu, Ming-Rong Zhang, Feng Wang, Rui Wang

Journal of Visualized Experiments · 2023

DOI: 10.3791/65047 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2023. Written by Lulu Zhang and 9 co-authors. Institution: Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University. Major MEDLINE topics: B7-H1 Antigen, Neoplasms. Cited 3 times so far (Crossref); 56 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

The development of immune checkpoint blockade therapy based on programmed cell death-protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) has revolutionized cancer therapies in recent years. However, only a fraction of patients responds to PD-1/PD-L1 inhibitors, owing to the heterogeneous expression of PD-L1 in tumor cells. This heterogeneity presents a challenge in the precise detection of tumor cells by the commonly used immunohistochemistry (IHC) approach. This situation calls for better methods to stratify patients who will benefit from immune checkpoint blockade therapy, to improve treatment efficacy. Positron emission tomography (PET) enables real-time visualization of the whole-body PD-L1 expression in a noninvasive way. Therefore, there is a need for the development of radiolabeled tracers to detect PD-L1 distribution in tumors through PET imaging. Compared to their L-counterparts, dextrorotary (D)-peptides have properties such as proteolytic resistance and remarkably prolonged metabolic half-lives. This study designed a new method to detect PD-L1 expression based on PET imaging of 68Ga-labeled PD-L1-targeted D-peptide, a D-dodecapeptide antagonist (DPA), in tumor-bearing mice. The results showed that the [68Ga]DPA can specifically bind to PD-L1-overexpressing tumors in vivo, and showed favorable stability as well as excellent imaging ability, suggesting that [68Ga]DPA-PET is a promising approach for the assessment of PD-L1 status in tumors.

Subjects

MeSH terms (MEDLINE)

B7-H1 AntigenNeoplasmsMiceAnimalsProgrammed Cell Death 1 ReceptorGallium RadioisotopesImmune Checkpoint InhibitorsPositron-Emission TomographyPeptides

Substances

CD274 protein, humanB7-H1 AntigenProgrammed Cell Death 1 ReceptorGallium RadioisotopesImmune Checkpoint InhibitorsPeptides

Authors and institutions

  • Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University.
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College.
  • Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College; Department of Advanced Nuclear Medicine S…
  • Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology; zhang.ming-rong@qst.go.jp.
  • Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University; fengwangcn@hotmail.com.

Cite

APA

Zhang, L., Zhang, S., Wu, W., Wang, X., Shen, J., Wang, D., Hu, K., Zhang, M. R., Wang, F., & Wang, R. (2023). Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression. Journal of Visualized Experiments. https://doi.org/10.3791/65047

Vancouver

Zhang L, Zhang S, Wu W, Wang X, Shen J, Wang D, et al. Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression. Journal of Visualized Experiments. 2023. doi:10.3791/65047

BibTeX
@article{Zhang2023,
  author = {Zhang, Lulu and Zhang, Siqi and Wu, Wenyu and Wang, Xingkai and Shen, Jieting and Wang, Dongyuan and Hu, Kuan and Zhang, Ming-Rong and Wang, Feng and Wang, Rui},
  title = {Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression},
  journal = {Journal of Visualized Experiments},
  year = {2023},
  doi = {10.3791/65047}
}
Start for free →